Professor, Chief Physician of the Department of Clinical Chemistry
University of Tampere School of Medicine, Finland
Terho Lehtimäki (T.L.), MD, PhD, eMBA is currently a professor (since 2002-) of Clinical Chemistry and Chief Physician of the Department of Clinical Chemistry, University of Tampere School of Medicine and Fimlab Laboratories (Ltd), Finland which is one of the largest clinical laboratory in Finland (800 workers, with 100 million eur revenue). His research interests are focused on cardiovascular disease risk factors, atherosclerosis biomarkers, vascular and cell biology and functional genetics and epigenetics of complex traits and diseases. He has extensive experience in genome-wide association studies and related bioinformatics, as well as other omics and high density SNP maps and deep sequencing in population-based samples. T.L have a total over 900 publications (782 in press, 7 rewievs, 20 other articles and 119 in revision/submitted/manuscript). T.L has actively participated in over 50 New England J Med, Science, Lancet, Nature, Nature Genetics papers over the last 5 years, and his work in collaboration with many international consortia has led to the discovery of over 1600 novel genetic variants of complex traits. T.L holds a patent on a novel diagnostic test to predict statin myopathy.
Cardiovascular disease risk factors, Atherosclerosis biomarkers, Vascular and cell biology and functional genetics and Epigenetics of complex traits and diseases.